

Everything you need to know about Quillichew ER: what it is, how it treats ADHD, available dosages, how to take it, and important safety information for 2026.
Quillichew ER is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. It contains methylphenidate hydrochloride, the same active ingredient found in well-known ADHD medications like Concerta and Ritalin.
What makes Quillichew ER unique is its form: it's an extended-release chewable tablet with a cherry flavor. This makes it especially helpful for children and adults who have trouble swallowing pills — a common barrier to ADHD treatment.
Quillichew ER is manufactured by Tris Pharma and marketed by Pfizer. It is classified as a Schedule II controlled substance by the DEA due to its potential for abuse and dependence.
Quillichew ER is FDA-approved for one indication:
ADHD is a neurodevelopmental condition characterized by inattention, hyperactivity, and impulsivity. Quillichew ER helps manage these symptoms by increasing the levels of certain brain chemicals (dopamine and norepinephrine) that play a role in attention and behavior. For a detailed explanation, see our article on how Quillichew ER works.
While other forms of methylphenidate are sometimes used off-label for narcolepsy or treatment-resistant depression, Quillichew ER is specifically designed and approved for ADHD.
Quillichew ER comes in three strengths:
The typical dose range is 20 mg to 60 mg once daily. Your doctor will usually start at a lower dose and adjust based on how you respond and any side effects you experience.
The ability to split tablets is a major advantage. It allows for more precise dosing — for example, a child might start at 10 mg (half of a 20 mg tablet) before moving to 20 mg.
Here are the key instructions for taking Quillichew ER correctly:
Quillichew ER is designed to release medication throughout the day — about 30% releases immediately and 70% releases gradually over several hours. Taking it in the morning ensures coverage during school or work hours while minimizing sleep-related side effects.
There are many ADHD medications on the market. Here's how Quillichew ER compares:
For a complete comparison, read our guide on alternatives to Quillichew ER.
Quillichew ER carries a boxed warning — the most serious type of FDA warning. It states that CNS stimulants, including Quillichew ER, have a high potential for abuse and dependence. Your doctor should assess your risk before prescribing and monitor you throughout treatment.
Do not take Quillichew ER if you:
Quillichew ER contains phenylalanine:
If you or your child has phenylketonuria (PKU), discuss this with your doctor before starting Quillichew ER.
There is limited data on Quillichew ER use during pregnancy. Methylphenidate is present in breast milk. Talk to your doctor about the risks and benefits if you are pregnant, planning to become pregnant, or breastfeeding.
The most common side effects include:
For a complete breakdown of what to watch for, read our detailed guide on Quillichew ER side effects.
Quillichew ER can interact with other medications, including MAOIs, blood pressure medications, blood thinners, and certain antidepressants. Always tell your doctor about every medication and supplement you take. See our full article on Quillichew ER drug interactions.
Quillichew ER costs approximately $300–$450 for 30 tablets without insurance. There is currently no generic version available.
Insurance coverage varies. Many plans require prior authorization, and some don't cover it at all. However, savings programs can significantly reduce your out-of-pocket cost:
For more cost-saving strategies, see our guide on how to save money on Quillichew ER.
Finding Quillichew ER in stock can also be a challenge due to the ongoing stimulant shortage. Use MedFinder to locate pharmacies with availability near you, or read our tips on finding Quillichew ER in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.